Best Dordaviprone (Dordaviprone) Medicine in India

Dordaviprone is a targeted anticancer treatment used to treat adults and children aged 1 year and older with H3 K27M-mutant diffuse midline glioma (DMG) that has progressed following prior therapy when no satisfactory alternative treatment options are available. It works by affecting specific molecular pathways involved in tumor-cell growth and survival, helping to slow the progression of this aggressive brain tumor.

Dordaviprone should be taken exactly as prescribed by your doctor. It is taken orally according to the recommended treatment schedule and should be used consistently throughout treatment. Regular medical check-ups and laboratory tests may be required to monitor your response to treatment and overall health.

Common side effects of Dordaviprone may include fatigue, decreased appetite, nausea, headache, vomiting, constipation, muscle or joint pain, and changes in liver function tests. Serious side effects may also occur in some patients. Inform your doctor if any side effect becomes severe or persistent, and tell your doctor about your medical history and all medicines, vitamins, and supplements you are taking before starting treatment.

Treatment of H3 K27M-Mutant Diffuse Midline Glioma

Dordaviprone is used to treat adults and children aged 1 year and older with H3 K27M-mutant diffuse midline glioma (DMG) that has progressed after prior treatment when there are no satisfactory alternative treatment options. It helps target molecular changes associated with the tumor, helping to control disease progression.

Some side effects of Dordaviprone may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Dordaviprone (Dordaviprone)

Take Dordaviprone exactly as prescribed by your doctor and follow the recommended treatment schedule carefully. It is taken orally and should be taken consistently as directed. Swallow it with water and follow your doctor's instructions regarding missed doses. Regular medical check-ups and laboratory tests may be required to monitor your response to treatment and overall health.

Dordaviprone is a targeted treatment that acts on molecular pathways involved in H3 K27M-mutant diffuse midline glioma (DMG). It helps restore activity in pathways affected by the H3 K27M mutation, which may interfere with tumor-cell growth and survival and help slow disease progression.

AlcoholCONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as dizziness, nausea, or fatigue. Follow your doctor's advice.

PregnancyCONSULT YOUR DOCTOR

Dordaviprone may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment and for the recommended period after the last dose, as the effects on a breastfed child are not fully known.

DrivingCONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience dizziness, fatigue, or other effects that may impair your alertness or coordination.

KidneyCAUTION

Inform your doctor if you have kidney problems. Your doctor may monitor kidney function and adjust treatment or provide appropriate medical care.

LiverCAUTION

Tell your doctor about any liver condition. Regular liver function tests may be required, and report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.